BioSpace

Sanofi’s MS Drug Fails Phase III Trial, While FDA Again Delays Approval Application

Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the ...

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The ...

FDA moves to expand sunscreen options, proposing ingredient used in Asia and Europe

The FDA has proposed adding bemotrizinol, a new sunscreen ingredient, to the U.S. approval list, which could expand consumer ...

FDA commissioner on public's growing mistrust in the government's health advice

NPR's Steve Inskeep asks FDA Commissioner Marty Makary about recent controversies around the COVID and Hepatitis B vaccines, and the lack of trust in the government's medical advice.

These moms are thankful for SSRIs during pregnancy. Now the drugs are an FDA flashpoint.

Medical experts are concerned that a panel discussion convened by the Food and Drug Administration could lead to more cases ...

FDA proposes allowing sunscreen ingredient already used in Europe and Asia

Bemotrizinol, a broad-spectrum chemical sunscreen ingredient, has long been used abroad. Experts say it offers better ...

Florida, Texas seek to overturn FDA's Mifepristone regulations, claiming mail access undermines state abortion laws

Florida and Texas have filed a lawsuit challenging more than two decades of federal government decisions that cleared the way ...

FDA proposes adding sunscreen ingredient commonly used in other parts of the world to list of permitted products

A new proposal from the US Food and Drug administration would allow sunscreens in the United States to include bemotrizinol ...

FDA approves first at-home device for depression. What is it?

The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to ...